Hepatic mitochondrial dysfunction has a critical role in the development of MASLD by increasing oxidative stress, contributing to inflammation and impaired hepatic insulin resistance (4). This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.